Serine/threonine kinase 33 is a protein that in humans is encoded by the STK33 gene.
STK33 was identified as a synthetic lethal gene in KRAS-dependent cell lines.
STK33 has been considered as a target for reversible male contraceptives and the inhibitor CDD-2807 has been tested successfully in mice.
References
- ^ GRCh38: Ensembl release 89: ENSG00000130413 – Ensembl, May 2017
- ^ GRCm38: Ensembl release 89: ENSMUSG00000031027 – Ensembl, May 2017
- "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- Spoonamore J, Weïwer M, Wei J, Guichard B, Ross NT, Masson K, et al. (2010). "Screen for Inhibitors of STK33 Kinase Activity". Probe Reports from the NIH Molecular Libraries Program . Bethesda (MD): National Center for Biotechnology Information (US). PMID 23658944.
- "Drug causes reversible male contraception in mice". 10 June 2024.
External links
- STK33+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
Enzymes | |
---|---|
Activity | |
Regulation | |
Classification | |
Kinetics | |
Types |
|
This membrane protein–related article is a stub. You can help Misplaced Pages by expanding it. |